Skip to main content

Albany Molecular Research, Inc. (NASDAQ:AMRI) Investor Investigation Over Possible Wrongdoing In Acquisition Announced

  • If you purchased shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) and currently hold any of those NASDAQ:AMRI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

June 15, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Albany Molecular Research, Inc. (NASDAQ:AMRI), was announced concerning whether the takeover of Albany Molecular Research, Inc. by The Carlyle Group and GTCR LLC for $21.75 per share is unfair to NASDAQ:AMRI stockholders. The investigation by a law firm concerns whether cert...



You must register (for free) or login to view the entire investigation.